These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 13617534)

  • 1. Complement-fixing antigens of living and inactivated poliovirus. II. Complement-fixing activity of poliomyelitis vaccine and its relation to immunogenic potency.
    WARREN J; HARE JD; GOLDMAN C
    Am J Public Health Nations Health; 1959 Jan; 49(1):53-61. PubMed ID: 13617534
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement-fixing antigens of live and inactivated poliovirus. III. Evaluation of a sensitive quantitative procedure for complement fixation.
    HARE JD; WARREN J
    Am J Hyg; 1958 Nov; 68(3):312-21. PubMed ID: 13594931
    [No Abstract]   [Full Text] [Related]  

  • 3. Complementfixing antigens of living and inactivated poliovirus. I. Complement-fixing antibody response of laboratory animals to poliovirus.
    HARE JD; WARREN J
    Am J Hyg; 1958 May; 67(3):350-66. PubMed ID: 13533408
    [No Abstract]   [Full Text] [Related]  

  • 4. Appearance of soluble and cross-reactive complement-fixing antigens on treatment of poliovirus with formalin.
    BLACK FL; MELNICK JL
    Proc Soc Exp Biol Med; 1955 Jul; 89(3):353-5. PubMed ID: 13254758
    [No Abstract]   [Full Text] [Related]  

  • 5. Complement-fixing antibody response to inactivated poliovirus vaccine.
    LENNETTE EH; SCHMIDT NJ; MAGOFFINRL
    J Immunol; 1961 Dec; 87():696-706. PubMed ID: 14464005
    [No Abstract]   [Full Text] [Related]  

  • 6. A phase contrast microprecipitin test with poliovirus antigens. II. Occurrence and development of microprecipitin antibody after natural inapparent infections, after inoculation of Salk vaccine, after feeding of attenuated live poliovirus vaccine, and in disease caused by polioviruses and other enteroviruses.
    EGGERS HJ; SABIN AB
    Arch Gesamte Virusforsch; 1961; 11():152-75. PubMed ID: 13725917
    [No Abstract]   [Full Text] [Related]  

  • 7. The safety test for poliomyelitis vaccine. III. Comparative sensitivity of rhesus and vervet monkeys to poliovirus.
    VAN HOOSIER GL; BARON S; KIRSCHSTEIN RL; ABINANTI FR
    Am J Hyg; 1962 Jan; 75():86-9. PubMed ID: 13924586
    [No Abstract]   [Full Text] [Related]  

  • 8. Detecting poliovirus in vaccine lots used in Idaho in 1955.
    EKLUND CM; HADLOW WJ; PICKENS EG; GERLOFF RK
    Public Health Rep (1896); 1959 Jan; 74(1):60-6. PubMed ID: 13623976
    [No Abstract]   [Full Text] [Related]  

  • 9. [SEROLOGICAL SURVEY OF CHILDREN FOR ANTIBODIES TO POLIOMYELITIS VIRUSES IN MOSCOW IN 1962].
    VOROSHILOVA MK; TARANOVA GP; EMELIANENKOVA VP; SHCHEGLOVA AP; KAPLAN SB
    Vopr Virusol; 1963; 29():404-9. PubMed ID: 14071275
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of live attenuated poliovirus vaccine.
    SKINNER RG
    J Fla Med Assoc (1914); 1960 May; 46():1387-9. PubMed ID: 13831482
    [No Abstract]   [Full Text] [Related]  

  • 11. The behavior of different strains of poliomyelitis virus in the complement fixation reaction. III. Comparison of the potency of complement fixing antigens derived from different strains of poliomyelitis virus.
    SCHMIDT NJ; LENNETTE EH; DENNIS J; HAGENS SJ
    J Immunol; 1960 Jul; 85():67-71. PubMed ID: 14443080
    [No Abstract]   [Full Text] [Related]  

  • 12. Measurement of the protective effect of attenuated poliovirus vaccine.
    KNOWELDEN J; HALE JH; GARDNER PS; LEE LH
    Br Med J; 1961 May; 1(5237):1418-20. PubMed ID: 13757211
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunization with live attenuated poliovirus vaccine.
    KRUGMAN S; WARREN J; EIGER MS; BERMAN PH; MICHAELS RM; SABIN AB
    Am J Dis Child; 1961 Jan; 101():23-9. PubMed ID: 13754588
    [No Abstract]   [Full Text] [Related]  

  • 14. Properties and behavior of orally administered attenuated poliovirus vaccine.
    SABIN AB
    J Am Med Assoc; 1957 Jul; 164(11):1216-23. PubMed ID: 13438685
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation and inactivation of purified poliovirus: comparison of vaccines derived from Mahoney and Parker poliovirus.
    CHARNEY J; FISHER WP; MACHLOWITZ RA
    Proc Soc Exp Biol Med; 1957 Dec; 96(3):601-5. PubMed ID: 13505802
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on poliomyelitis virus. II. The immunogenic potency of live and inactivated virus in guinea-pigs.
    HAMPTON JW; POLSON A; SELZER G
    J Hyg (Lond); 1958 Jun; 56(2):260-5. PubMed ID: 13563867
    [No Abstract]   [Full Text] [Related]  

  • 17. Status of field trials with an orally administered, live attenuated poliovirus vaccine.
    SABIN AB
    J Am Med Assoc; 1959 Oct; 171():863-8. PubMed ID: 14440556
    [No Abstract]   [Full Text] [Related]  

  • 18. Response of Cuban children to oral vaccination with living attenuated poliovirus vaccines. A clinical and serological study.
    EMBIL J
    Br Med J; 1960 Apr; 1(5180):1157-62. PubMed ID: 13820150
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccination with Koprowski's live attenuated polio vaccine in the area of Gdansk and Olsztyn provinces. II. Results of viral examinations of persons vaccinated with live, attenuated poliovirus vaccine.
    GEORGIADES J; MORZYCKA M; MAKAREWICZ J; RODKIEWICZ T
    Biul Inst Med Morsk Gdansk; 1961; 12():29-36. PubMed ID: 13897793
    [No Abstract]   [Full Text] [Related]  

  • 20. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
    GUENTHER O; HOEVEL H; VON METTENHEIM
    Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.